Obesity is the first thing you see. Don’t make it the last thing you talk about
Obesity is associated with at least 60 comorbidities, some of which can be improved through weight loss.1-4
While the majority of patients and HCPs agree that weight loss of 10% may be beneficial to their health, patients may be waiting for HCPs to take that important first step and discuss weight management.5*
*Data from a survey that examined obesity-related perceptions, attitude, and behaviors among ~3,000 adults with obesity and ~600 HCPs.
It’s time to bring obesity to the forefront
Weight-related comorbidities are just that: medical conditions that may often be associated with obesity.
Weight loss of 5% to 15% or greater may result in improvements in many of these comorbidities2:
Obesity is associated with many common CVD risk factors, including7:
Weight loss can help improve some of your patients' weight-related comorbidities
For a deeper look into some of these conditions, tap on each weight-related comorbidity to explore the role obesity can play in your patients’ health.
Nonalcoholic fatty liver disease (NAFLD)
Polycystic ovary syndrome (PCOS)
Obstructive sleep apnea (OSA)
Comorbidities of obesity brochure
This brochure includes an overview of some common weight-related comorbidities and the impact weight loss may have on them.
Obesity is caused by a range of factors
1. Bays HE, McCarthy W, Christensen S, et al. Obesity algorithm 2020. Presented by the Obesity Medicine Association. Accessed November 21, 2022. https://obesitymedicine.org/obesity-algorithm
2. Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187-194.
3. Garvey WT, Mechanick JI, Brett EM; and Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203.
4. Cancers associated with overweight and obesity make up 40 percent of cancers diagnosed in the United States. Centers for Disease Control and Prevention. Accessed November 22, 2022. https://www.cdc.gov/media/releases/2017/p1003-vs-cancer-obesity.html
5. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from the national ACTION study. Obesity (Silver Spring). 2018;26(1):61-69.
6. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711-719.
7. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984-e1010.
8. Le MH, Yeo YH, Li X, et al. 2019 global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20(12):2809-2817.e28.
9. Cotter TG, Rinella M. NAFLD 2020: the state of the disease. Gastroenterology. 2020;158(7):1851-1864.
10. Metabolic syndrome. Mayoclinic.org. Accessed November 24, 2020. https://www.mayoclinic.org/diseases-conditions/metabolic-syndrome/symptoms-causes/syc-20351916
11. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Care. 2011;34(7):1481-1486.